Your account is not claimed yet. You can sign up with ORCID to claim your account.

Daniela Barros-Silva

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Venues

Genes

Cancers

Journal of experimental & clinical cancer research : CR

Metabolomics : Official journal of the Metabolomic Society

Instituto Português de Oncologia do Porto Francisco Gentil EPE

University of Porto (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto Português de Oncologia do Porto Francisco Gentil EPE Mar 1o 2018

Portugal

Research Assistant :: Cancer Epigenetics Group

Education History

University of Porto Sep 15o 2015 - Oct 15o 2017

Portugal

MSC :: Institute of Biomedical Sciences Abel Salazar

Publications

José Pedro Sequeira, Daniela Barros-Silva, Patrícia Ferreira-Torre, Sofia Salta, Isaac Braga, João Carvalho, Rui Freitas, Rui M Henrique, Carmen Jerónimo
OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach. International journal of molecular sciences 24 (18) (2023)
João Lobo, Nuno Tiago Tavares, Daniela Barros-Silva, Alina Rosinha, António Morais, Carmen Jerónimo, Ângelo Rodrigues, Rui M Henrique
MiR-371a-3p in cystic trophoblastic tumour of the testis: supporting a maturation phenomenon towards teratoma. Histopathology (2023)
Daniela Barros-Silva, Johan Tsui, Carmen Jerónimo, Guido W Jenster, Elena S Martens-Uzunova
Site-specific analysis of ribosomal 2'O-methylation by quantitative reverse transcription PCR under low deoxynucleotide triphosphate concentrations. BioTechniques (2023)
Tânia Lima, António S Barros, Fábio Trindade, Rita Ferreira, Adelino F Leite-Moreira, Daniela Barros-Silva, Carmen Jerónimo, Luís Araújo, Rui M Henrique, Rui Vitorino, Margarida Fardilha
Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. Cancers 14 (8) (2022)
Catarina Guimarães-Teixeira, João Lobo, Vera Miranda-Gonçalves, Daniela Barros-Silva, Cláudia Martins-Lima, Sara Monteiro-Reis, José Pedro Sequeira, Isa Carneiro, Margareta P Correia, Rui M Henrique, Carmen Jerónimo
Downregulation of m 6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness. Molecular oncology 16 (9) (2022)
José Pedro Sequeira, Vera Constâncio, Sofia Salta, João Lobo, Daniela Barros-Silva, Carina Carvalho-Maia, Jéssica Rodrigues, Isaac Braga, Rui M Henrique, Carmen Jerónimo
LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma. Cancers 14 (4) (2022)
Daniela Barros-Silva, Jonathan Klavert, Guido W Jenster, Carmen Jerónimo, Denis L J Lafontaine, Elena S Martens-Uzunova
The role of OncoSnoRNAs and Ribosomal RNA 2'-O-methylation in Cancer. RNA biology (2021)
Catarina Guimarães-Teixeira, Daniela Barros-Silva, João Lobo, Diana Soares-Fernandes, Vera Constâncio, Pedro Leite-Silva, Rui Silva-Santos, Isaac Braga, Rui M Henrique, Vera Miranda-Gonçalves, Carmen Jerónimo
Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes. Journal of personalized medicine 11 (10) (2021)
Vera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, Rita Guimarães, Mariana Cantante, Isaac Braga, Joaquina Maurício, Christoph Oing, Friedemann Honecker, Daniel Nettersheim, Leendert H J Looijenga, Rui M Henrique, Carmen Jerónimo
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Ana Rita Lima, Joana Pinto, Daniela Barros-Silva, Carmen Jerónimo, Rui M Henrique, Maria de Lourdes Bastos, Márcia Carvalho, Paula Guedes de Pinho
New findings on urinary prostate cancer metabolome through combined GC-MS and 1H NMR analytical platforms. Metabolomics : Official journal of the Metabolomic Society 16 (6) (2020)
Inês Maria Guerreiro, Daniela Barros-Silva, Paula Lopes, Mariana Cantante, Ana Luísa Cunha, João Lobo, Luís Antunes, Ana Rodrigues, Marta Soares, Rui M Henrique, Carmen Jerónimo
RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer. Journal of clinical medicine 9 (4) (2020)
Ana Rita Lima, Joana Pinto, Ana Isabel Azevedo, Daniela Barros-Silva, Carmen Jerónimo, Rui M Henrique, Maria de Lourdes Bastos, Paula Guedes de Pinho, Márcia Carvalho
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. British journal of cancer 121 (10) (2019)
Vera Constâncio, Daniela Barros-Silva, Carmen Jerónimo, Rui M Henrique
Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies. Expert review of molecular diagnostics 19 (5) (2019)
Bárbara Vilela-Salgueiro, Daniela Barros-Silva, João Lobo, Ana Laura Costa, Rita Guimarães, Mariana Cantante, Paula Lopes, Isaac Braga, Jorge Oliveira, Rui M Henrique, Carmen Jerónimo
Germ cell tumour subtypes display differential expression of microRNA371a-3p. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 373 (1748) (2019)
Daniela Barros-Silva, C Joana Marques, Rui M Henrique, Carmen Jerónimo
Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications. Genes 9 (9) (2018)
João Lobo, Daniela Barros-Silva, Rui M Henrique, Carmen Jerónimo
The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors. Genes 9 (11) (2018)

Daniela Barros-Silva.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniela Barros-Silva